Article Information
History
- December 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- L.M. Bek1,*,
- J.C. Berentschot2,*,
- M.H. Heijenbrok-Kal1,3,
- S. Huijts2,
- M.E. van Genderen4,
- J.H. Vlake4,
- J. van Bommel4,
- J.G.J.V. Aerts2,
- G.M. Ribbers1,3,
- H.J.G. van den Berg-Emons1,**,
- M.E. Hellemons2,**,† and
- on behalf of the CO-FLOW collaboration Group***
- 1Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
- 2Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
- 3Rijndam Rehabilitation, Rotterdam, The Netherlands
- 4Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands
- ↵†Correspondence:
M.E. Hellemons, Department of Respiratory Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands, m.hellemons{at}erasmusmc.nl
Posted December 13, 2021.
Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study
